Tag: partnership

UK and France launch biomedical and AI health alliance to accelerate research into major diseases

UK and France launch biomedical and AI health alliance to accelerate research into major diseases

A new partnership will unite expertise, infrastructure and data across borders to accelerate diagnosis, treatment and ultimately prevention of major diseases – starting with women’s health, infectious diseases and pandemic preparedness.

Diamond Light Source, the University of Oxford, Université Paris Cité, the Institut Pasteur and Synchrotron SOLEIL have signed a landmark agreement establishing a major new UK-France scientific alliance designed to strengthen how diseases are understood, diagnosed, treated and ultimately prevented.

The partnership comes at a time when advances in science and technology are generating unprecedented amounts of biological and clinical data, as well as transforming our understanding of human health. But turning that information into faster diagnoses, better treatments and improved disease prevention remains a major challenge across disciplines, institutions and national systems.

The UK–France Strategic Biomedical Alliance in Health and AI has been established to address that challenge by connecting world-leading expertise and national infrastructure into a single collaboration. The interdisciplinary model will unite clinical research, molecular biology, engineering, advanced imaging, data science, artificial intelligence and translational medicine across both countries, making it faster and easier for researchers to connect the technologies, expertise and data needed to tackle complex disease.  

Read more on the Diamond website

Image: Dr Jean Susini, Director General, Synchrotron SOLEIL. Sir Thomas Drew KCMG, His Majesty’s Ambassador to France. Professor Richard Cornall, Head of the Nuffield Department of Medicine, University of Oxford. Professor Matthieu Resche-Rigon, Dean of the Health Faculty, Université Paris Cité. Jean-Luc Moullet, Director General for Research and Innovation, French Ministry of Higher Education, Research and Space. Dr Martin Walsh, Interim Director of Life Sciences, Diamond Light Source. Dr Odette Tomescu-Hatto, Director of International Affairs, Institut Pasteur.

Credit: The Department for Science, Innovation and Technology (DSIT)

Cancer Research Horizons and Diamond Light Source establish drug discovery partnership

Cancer Research Horizons and Diamond Light Source establish drug discovery partnership

Cancer Research Horizons, the innovation arm of Cancer Research UK, is partnering with Diamond Light Source, the UK’s national synchrotron, to build a world-leading fragment-based drug discovery programme

Diamond Light Source accelerates electrons to near light speed, producing bright light that is directed into research instruments known as beamlines. Cancer Research Horizons and its drug discovery site at Newcastle University have already been using Diamond’s beamlines and XChem facility for fragment-based screening, a powerful approach to identify chemical entities that can be developed rapidly into potent candidates.

The new partnership will build on this existing relationship to improve the throughput, running and analysis of these experiments. By leveraging their combined expertise and resources, the partnership aims to accelerate the drug discovery process and help bring new cancer treatments to patients faster.

Under the agreement, Cancer Research Horizons will fund two on-site postdoctoral research assistants dedicated to optimising the delivery of its in-house and industry-partnered projects. In return, Diamond will provide early access to any proprietary developments to its platform.

The partnership will establish a governance framework to enable Cancer Research Horizons to provide feedback on the industrialisation of Diamond’s Fragment Screening platform. This initiative aims to enhance its appeal to Cancer Research Horizons’ pharmaceutical and biotech partners, driving broader industry engagement.

Read more on Diamond website